Global Protein Sequencer Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Protein Sequencer Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Protein sequencing is a popular de novo sequencing method for the determination and analysis of the amino acid sequence from the mass spectrum. The process enables researchers obtain information about protein conformation. Protein sequencing has established itself as high-throughput proteomic technique and have several applications. One of the prominent applications is in target-based drug discovery. A Protein Sequencer is the machinery for the sequencing process. A range of various computational methods and experimental methods, notably Edman degradation and Mass Spectrometry, is used for protein sequencing.

Market Overview:

The latest research study on the global Protein Sequencer market finds that the global Protein Sequencer market reached a value of USD 48.02 million in 2022. It’s expected that the market will achieve USD 54.98 million by 2028, exhibiting a CAGR of 2.28% during the forecast period.

Challenges from COVID-19

At present, the number of confirmed cases in Worldwide has exceeded 27 million. It has begun to feel the global impact of coronavirus disease (COVID-19) in 2019 and affect the Protein Sequencer market in 2020 in a certain way.

Different industries are affected differently by the epidemic situation. The impact on Protein Sequencer is mainly reflected in the supply of material and operation of the market. Affected by the COVID-19 epidemic, logistics will be suspended and the supply of Protein Sequencer will be tight. Due to the global threat of COVID-19, the resumption of work in the factory will directly affect the customer's production plan for goods and shipments. The continuous outbreak of the international epidemic situation, if the personnel control of each country is extended, it will affect the smooth supply of equipment and materials.

During the outbreak of COVID-19, Protein Sequencer's main operational impacts are business continuity planning, management of flexible work arrangements, management of employee communication, addressing employees' concerns about workplace policies, implementing preventive measures, reviewing current welfare policies, etc. Demand for home isolation, management efficiency of large and small companies has declined, commuting has been severely hindered, sales plans have been severely hindered, network expansion has been delayed, marketing has been delayed, brand adjustments have been forced, market sales have declined, and company and employee revenue have declined.

The need for protein sequencing and the continuous development of related sequencing technologies and methods

Protein is indispensable to living systems and is the main carrier of biological functions. They can be used as chemical catalysts, structural components and mediators of physiological processes. Research techniques that accurately identify and quantify proteins can greatly promote people's understanding of biology. For many diseases that cannot be explained at the genetic level, protein can give people the answers people want. Even if some diseases can be explained at the genetic level, they may have to come back to protein during treatment; for this reason, proteomics has come into being. Scientists predict that with the completion of human genome sequencing, the focus of future life science research may shift from genomics to proteomics.

The high cost of the instrument and the demand for high-quality labor

Protein de novor is a field that spans proteomics and bioinformatics, and requires high equipment, personnel and analysis software. Therefore, the factors that affect the accuracy of protein de novor mainly include equipment, personnel and related analysis software. At present, mainstream sequencing services basically require the use of high-resolution mass spectrometers. The instrument itself is relatively expensive and the maintenance cost is high, which will bring corresponding economic pressure on buyers;
Second, the lack of well-trained researchers and laboratory professionals is restricting the growth of the Protein Sequencer market. In recent years, the field of proteomics has developed rapidly in protein production, crystal growth and structure determination technology. In addition, since the use of sequencing technology and instruments involves complex operations, professionals are required to complete the entire process.

Region Overview:

In 2021, the share of the Protein Sequencer market in North America stood at 35.27%.

Company Overview

Shimadzu is one of the major players operating in the Protein Sequencer market, holding a share of 100% in 2020.

Shimadzu Protein Sequencer

Shimadzu Corporation is a precision tools and equipment maker. The Company develops, manufactures, and sells analytical and measuring instruments, medical systems, and aircraft and industrial equipment. Shimadzu researches, develops, and markets the products through its related companies in Japan, the US, the UK, China and Other countries.

Segmentation Overview:

By type, Edman segment accounted for the largest share of market in 2021.

MS

Mass spectrometry is one of the most important analytical techniques in the field of protein research and biological macromolecule research. Due to the increasing requirements for protein identification, quantification and analysis, it is hoped that the sensitivity of the detection technology will also be higher and higher, and at the same time more complex samples can be analyzed and processed. This has promoted the development of mass spectrometry detection technology, and a large number of emerging mass spectrometry methods and instruments.

Edman

Edman degradation is a sensitive, and simple way to infer the location of phosphoamino acids in an isolated phosphopeptide. Edman degradation is an important technique in protein sequence analysis. It includes step by step hydrolysis of peptides with phenyl isothiocyanate, beginning at the N-terminus of the polypeptide.

Application Overview:

By application, the Genetic Engineering segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Protein Sequencer market covered in Chapter 3:

Shimadzu

In Chapter 4 and Chapter 14.2, on the basis of types, the Protein Sequencer market from 2018 to 2029 is primarily split into:

MS
Edman

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Protein Sequencer market from 2018 to 2029 covers:

Biotherapeutics
Genetic Engineering

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)